| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 196,094 shares worth roughly $15.4M.
Classified under Biotechnology (Health Care sector), IONS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 156.0K | $8.82M | - | |
| CEO | 99.9K | $5.65M | - | |
| CFO | 82.7K | $4.68M | - | |
| VP | 74.4K | $4.21M | - | |
| VP | 69.7K | $3.94M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2019 | Crooke Stanley T | Chairman And CEO | Sale+OE | 77,000 | $60.77 | $4,679,498.70 | -35.6% | |
| Feb 13, 2019 | Geary Richard S65 | SVP, Development | Sell | 999 | $60.00 | $59,940.00 | -4.5% | |
| Feb 13, 2019 | Crooke Stanley T | Chairman And CEO | Sale+OE | 46,904 | $60.09 | $2,818,268.00 | -36.8% | |
| Feb 12, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 275 | $59.50 | $16,362.50 | -1.4% | |
| Feb 5, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 19,600 | $59.25 | $1,161,360.00 | -33.3% | |
| Feb 1, 2019 | Bennett C Frank64 | SVP, Antisense Research | Sale+OE | 9,013 | $58.29 | $525,367.77 | -26.9% | |
| Jan 3, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 4,400 | $54.80 | $241,120.00 | -13.1% | |
| Jan 2, 2019 | Monia Brett P60 | Chief Operating Officer | Sell | 214 | $53.50 | $11,449.00 | -1.3% |